Saturday, October 3, 2026

USD/CNH Bearish Momentum With A 2% Drop In The Last 10 Sessions

USD/CNH Bearish Momentum With A 2% Drop In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 2.1% for the last 10 sessions. At 05:10 EST on Tuesday, 12 March, USD/CNH (USDCNH) is $7.18.

USD/CNH's yearly highs and lows, it's 0.004% up from its 52-week low and 0.129% down from its 52-week high.

News about

  • According to FXStreet on Tuesday, 12 March, "Eren Sengezer, European Session Lead Analyst at FXStreet, offers a brief technical outlook for EUR/USD and explains: "The Relative Strength Index (RSI) indicator on the daily chart edged lower after coming within a touching distance of 70, suggesting that investors are taking a break before betting on another leg higher in EUR/USD. "
  • Eur/usd: an acceleration to 1.1000 will most likely depend on US cpi, if not retail sales – socgen. According to FXStreet on Monday, 11 March, "For the week ahead, investors chasing a rally in EUR/USD above 1.1000 will brace for US Consumer Price Index (CPI) report and US Retail Sales, economists at Société Générale say"
  • Eur/usd hints at weakness to come. According to FXStreet on Monday, 11 March, "Turning to the charts, the overall short-term picture for EUR/USD is that the pair has been rising since February in an uptrend that continues to slightly favor bulls, but there are increasing signs a correction may be about to unfold."
  • According to FXStreet on Monday, 11 March, "The Euro was little affected by Kazimir's comments, keeping EUR/USD unperturbed near 1.0940."
  • Eur/usd forex signal: more gains likely ahead of US CPI report - 11 March 2024. According to DailyForex on Monday, 11 March, "The EUR/USD exchange rate continued rising last week after the European Central Bank (ECB) decision and the US non-farm payrolls (NFP) data. ", "Meanwhile, the EUR/USD pair reacted to the two-day testimony by Jerome Powell, the head of the Federal Reserve. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com